Search for: "Teva Investor Group"
Results 1 - 14
of 14
Sorted by Relevance
|
Sort by Date
9 Jan 2023, 9:01 pm
Teva Pharmaceutical The $420 million settlement between Teva and investors resolves allegations that the company engaged in a generic drug price-fixing conspiracy that allowed it to drastically raise prices on generic drugs from 2013 to 2015 – as high as 1,000%. [read post]
2 Sep 2009, 2:23 pm
Teva Pharmaceutical Industries Ltd. v. [read post]
16 May 2019, 9:30 am
Silver Law Group represents investors in securities and investment fraud cases. [read post]
28 May 2008, 8:56 am
" ``This is an unprecedented situation,'' said Jeff Glenzer, a managing director at the Association for Financial Professionals, a 16,000-member trade group. [read post]
5 Jan 2023, 2:22 pm
Teva Pharmaceutical The $420 million settlement between Teva and investors resolves allegations that the company engaged in a generic drug price-fixing conspiracy that allowed it to drastically raise prices on generic drugs from 2013 to 2015 – as high as 1,000%. [read post]
21 Mar 2015, 6:26 am
Teva, No. 1:14-cv-00941 (D. [read post]
19 Jan 2023, 4:10 pm
In addition, manufacturers Teva and Allergan reached multi-state agreements, agreeing to pay more than $7 billion in total. [read post]
31 Oct 2018, 5:09 pm
The complaint, a copy of which can be found here, purports to be filed on behalf of investors who purchased their McKesson securities between October 24, 2013 and January 25, 2017. [read post]
8 Aug 2018, 1:51 pm
Greene’s Energy Group and Impressions Products v. [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46) Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont… [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real… [read post]
15 Oct 2018, 7:05 am
Justice Kavanaugh being seated prior to the second week of oral arguments in October means that most of the cases on the docket in the October Term will be heard by a complete Court of 9 Justices; thus avoiding the dreaded 4-4 split. [read post]
18 Jun 2019, 6:42 am
Brief Overview: The stockholder demand in this case stated as its purpose the investigation of mismanagement, including depriving investors of their right of first refusal under an investors’ agreement that was amended without the consent of all investors, as well as interfering with the sale of stock by a large stockholder. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) – Lundbeck wins… [read post]
